For example, programmed cell death protein 1 (PD-1) and its ligands PD-L1 and PD-L2 are revolutionizing cancer treatment in lung cancer, melanoma, Hodgkin’s lymphoma, and several other forms of cancer [97]. This evidence concerns the gene PDCD1 and lung carcinoma.